These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17458097)

  • 1. The clinical and radiological assessment of periodontal bone loss treatment using Emdogain.
    Tokajuk G; Pawińska M; Kedra BA
    Adv Med Sci; 2006; 51 Suppl 1():227-9. PubMed ID: 17458097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report study of 72 consecutive Emdogain-treated intrabony periodontal defects: clinical and radiographic findings after 1 year.
    Heden G
    Int J Periodontics Restorative Dent; 2000 Apr; 20(2):127-39. PubMed ID: 11203555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial.
    Bhutda G; Deo V
    Acta Odontol Scand; 2013; 71(3-4):764-70. PubMed ID: 23078573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intrabony pockets with Emdogain: results at 36 months.
    Parodi R; Santarelli GA; Gasparetto B
    Int J Periodontics Restorative Dent; 2004 Feb; 24(1):57-63. PubMed ID: 14984146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G; Wennström JL
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Emdogain in the treatment of deep intrabony defects: 12-month clinical results. Histologic and radiographic evaluation.
    Parodi R; Liuzzo G; Patrucco P; Brunel G; Santarelli GA; Birardi V; Gasparetto B
    Int J Periodontics Restorative Dent; 2000 Dec; 20(6):584-95. PubMed ID: 11203595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain).
    Sculean A; Chiantella GC; Windisch P; Donos N
    Int J Periodontics Restorative Dent; 2000 Aug; 20(4):374-81. PubMed ID: 11203577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emdogain: evidence of efficacy.
    Greenstein G
    Compend Contin Educ Dent; 2000 Apr; 21(4):299-305, 308, 310 passim; quiz 314. PubMed ID: 11199682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ready-to-use EMDOGAIN-gel and EMDOGAIN in patients with chronic adult periodontitis.
    Bratthall G; Lindberg P; Havemose-Poulsen A; Holmstrup P; Bay L; Söderholm G; Norderyd O; Andersson B; Rickardsson B; Hallström H; Kullendorff B; Sköld Bell H
    J Clin Periodontol; 2001 Oct; 28(10):923-9. PubMed ID: 11686810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects.
    Bokan I; Bill JS; Schlagenhauf U
    J Clin Periodontol; 2006 Dec; 33(12):885-93. PubMed ID: 17092241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of macrophages in the periodontal regeneration using Emdogain gel.
    Fujishiro N; Anan H; Hamachi T; Maeda K
    J Periodontal Res; 2008 Apr; 43(2):143-55. PubMed ID: 18302615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiographic evaluation of periodontal therapy using enamel matrix derivative (Emdogain).
    Pietruska MD; Pietruski JK; Stokowska W
    Rocz Akad Med Bialymst; 2001; 46():198-208. PubMed ID: 11780564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontal regeneration with enamel matrix derivative--case reports.
    Manor A
    J Int Acad Periodontol; 2000 Apr; 2(2):44-8. PubMed ID: 12666960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects.
    Zetterström O; Andersson C; Eriksson L; Fredriksson A; Friskopp J; Heden G; Jansson B; Lundgren T; Nilveus R; Olsson A; Renvert S; Salonen L; Sjöström L; Winell A; Ostgren A; Gestrelius S
    J Clin Periodontol; 1997 Sep; 24(9 Pt 2):697-704. PubMed ID: 9310875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomised clinical trial.
    Grusovin MG; Esposito M
    Eur J Oral Implantol; 2009; 2(1):43-54. PubMed ID: 20467617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oral surgeon's evaluation of Emdogain.
    Trieger N
    N Y State Dent J; 2003 Nov; 69(9):31-3. PubMed ID: 14702763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases.
    Sculean A; Reich E; Chiantella GC; Brecx M
    Int J Periodontics Restorative Dent; 1999 Apr; 19(2):157-63. PubMed ID: 10635181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.